08.05.2020
Prevent & Delay
$916,224.00
60 months
Stimulated glucagon levels as a biomarker of hypoglycemia risk in type 1 diabetes
Funds support laboratory and clinical studies into measuring and understanding dysfunctional secretion of glucagon in type 1 diabetes (T1D).